PATIENCE JOHN 4
4 · BIODESIX INC · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Biodesix (BDSX) Chairman John Patience Converts 1,361 RSUs
What Happened
John Patience, Chairman and a director of Biodesix (BDSX), reported the vesting/conversion of 1,361 restricted stock units (RSUs) into 1,361 shares on June 30, 2026. The Form 4 records the derivative conversion under transaction code M (exercise/conversion of a derivative). The entries show no cash exchanged (price reported as $0.00 and total value $0), indicating these were vesting/settlement events rather than open-market purchases or sales.
Key Details
- Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (filed within the typical 2-business-day window).
- Reported transactions: 1,361 shares acquired via conversion of derivative (RSU) and an associated derivative disposition recorded at $0.00.
- Price/Value: $0.00 reported for the disposition; no cash consideration shown.
- Shares owned after the transaction: not specified in this filing.
- Footnotes:
- F1: Each RSU equals a contingent right to one share.
- F4: These RSUs vest in four equal installments (Mar 31, Jun 30, Sep 30, Dec 31, 2026) and have no expiration date — this was the June 30 vesting installment.
- F2/F3: Reporting person has interests through Patience Enterprises LP and a living trust and disclaims beneficial ownership except to the extent of pecuniary interest.
Context
This was a compensation-related vesting/settlement of RSUs, not a market purchase or sale. The filing does not show any immediate open-market sale of the shares (no cashless exercise or sale reported). Such vesting events are routine executive compensation and do not by themselves indicate a buy or sell signal.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-30+1,361→ 25,383 total - Exercise/Conversion
Restricted Stock Units
[F1][F4]2026-06-30−1,361→ 2,721 total→ Common Stock (1,361 underlying)
- 107,664(indirect: By Patience Enterprises LP)
Common Stock
[F2] - 241,480(indirect: By Trust)
Common Stock
[F3] - 2,649(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
- [F2]The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
- [F3]The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
- [F4]These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.